| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 86 | 2024 | 11101 | 3.970 |
Why?
|
| Receptors, Androgen | 26 | 2024 | 1089 | 3.190 |
Why?
|
| Polymorphism, Single Nucleotide | 82 | 2024 | 16041 | 2.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 13 | 2020 | 451 | 2.050 |
Why?
|
| Genetic Predisposition to Disease | 83 | 2024 | 18062 | 2.030 |
Why?
|
| Genome-Wide Association Study | 54 | 2024 | 12795 | 1.950 |
Why?
|
| Quantitative Trait Loci | 22 | 2024 | 2131 | 1.850 |
Why?
|
| Gene Expression Regulation, Neoplastic | 32 | 2024 | 8637 | 1.510 |
Why?
|
| Carcinoma, Renal Cell | 14 | 2024 | 3187 | 1.240 |
Why?
|
| Enhancer Elements, Genetic | 14 | 2024 | 1367 | 1.110 |
Why?
|
| Epigenomics | 10 | 2024 | 959 | 1.090 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 4 | 2022 | 165 | 1.050 |
Why?
|
| Neuroendocrine Tumors | 3 | 2024 | 659 | 1.000 |
Why?
|
| Kidney Neoplasms | 15 | 2024 | 4282 | 0.960 |
Why?
|
| Alleles | 26 | 2023 | 6894 | 0.960 |
Why?
|
| Chromatin | 12 | 2024 | 2981 | 0.920 |
Why?
|
| Germ-Line Mutation | 10 | 2022 | 1883 | 0.910 |
Why?
|
| Ovarian Neoplasms | 17 | 2024 | 4915 | 0.870 |
Why?
|
| Prostate | 12 | 2023 | 1765 | 0.840 |
Why?
|
| Histone Code | 2 | 2021 | 160 | 0.830 |
Why?
|
| Breast Neoplasms | 39 | 2022 | 21206 | 0.830 |
Why?
|
| Neoplasms, Glandular and Epithelial | 5 | 2022 | 489 | 0.800 |
Why?
|
| Carcinoma, Neuroendocrine | 3 | 2024 | 343 | 0.780 |
Why?
|
| Cell Line, Tumor | 34 | 2024 | 17128 | 0.750 |
Why?
|
| Genetic Loci | 10 | 2017 | 2629 | 0.720 |
Why?
|
| Genes, BRCA2 | 3 | 2021 | 593 | 0.670 |
Why?
|
| Genetic Association Studies | 9 | 2021 | 2744 | 0.630 |
Why?
|
| Haplotypes | 17 | 2011 | 2722 | 0.610 |
Why?
|
| Neoplasms, Hormone-Dependent | 3 | 2011 | 409 | 0.600 |
Why?
|
| Neoplasms | 16 | 2023 | 22365 | 0.590 |
Why?
|
| Chromosome Mapping | 15 | 2020 | 4618 | 0.570 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2022 | 998 | 0.530 |
Why?
|
| Gene Amplification | 5 | 2019 | 1088 | 0.510 |
Why?
|
| DNA Methylation | 7 | 2024 | 4426 | 0.510 |
Why?
|
| Genetic Variation | 19 | 2022 | 6611 | 0.500 |
Why?
|
| Humans | 247 | 2024 | 767991 | 0.500 |
Why?
|
| Male | 141 | 2024 | 364641 | 0.490 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 4 | 2010 | 126 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2015 | 370 | 0.470 |
Why?
|
| Epigenesis, Genetic | 10 | 2024 | 3834 | 0.470 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 6 | 2023 | 792 | 0.460 |
Why?
|
| Carboplatin | 1 | 2017 | 791 | 0.450 |
Why?
|
| Genotype | 31 | 2019 | 13042 | 0.440 |
Why?
|
| Androgen Antagonists | 6 | 2022 | 1412 | 0.440 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2010 | 1942 | 0.430 |
Why?
|
| Androgens | 6 | 2022 | 1281 | 0.420 |
Why?
|
| Phenylthiohydantoin | 4 | 2024 | 207 | 0.410 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2012 | 61 | 0.400 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2012 | 93 | 0.400 |
Why?
|
| Estrogen Receptor beta | 2 | 2010 | 171 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2024 | 2846 | 0.390 |
Why?
|
| Case-Control Studies | 30 | 2024 | 22287 | 0.390 |
Why?
|
| DNA, Neoplasm | 3 | 2015 | 1742 | 0.390 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 4 | 2010 | 416 | 0.390 |
Why?
|
| Pyrophosphatases | 1 | 2012 | 142 | 0.390 |
Why?
|
| Germ Cells | 4 | 2022 | 644 | 0.380 |
Why?
|
| Genetic Markers | 6 | 2019 | 2602 | 0.380 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2010 | 24 | 0.370 |
Why?
|
| Acetylation | 4 | 2023 | 1055 | 0.360 |
Why?
|
| Linkage Disequilibrium | 15 | 2020 | 1997 | 0.350 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2010 | 62 | 0.350 |
Why?
|
| Inositol | 1 | 2011 | 216 | 0.350 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2011 | 707 | 0.340 |
Why?
|
| Genes, myc | 2 | 2022 | 391 | 0.340 |
Why?
|
| Risk | 16 | 2020 | 9609 | 0.340 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2011 | 101 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2010 | 275 | 0.340 |
Why?
|
| Genetics, Population | 6 | 2010 | 943 | 0.330 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2011 | 186 | 0.330 |
Why?
|
| Mutation | 16 | 2024 | 30211 | 0.330 |
Why?
|
| Gene Expression Profiling | 8 | 2021 | 9536 | 0.320 |
Why?
|
| Breast | 2 | 2013 | 1976 | 0.320 |
Why?
|
| BRCA2 Protein | 3 | 2020 | 802 | 0.320 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2020 | 480 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2009 | 418 | 0.310 |
Why?
|
| Transcription Factors | 11 | 2023 | 12165 | 0.300 |
Why?
|
| Homeodomain Proteins | 4 | 2022 | 2429 | 0.300 |
Why?
|
| Frontal Lobe | 4 | 2001 | 1427 | 0.300 |
Why?
|
| Aged | 77 | 2024 | 171446 | 0.300 |
Why?
|
| Genetic Research | 4 | 2009 | 173 | 0.300 |
Why?
|
| BRCA1 Protein | 4 | 2020 | 1155 | 0.290 |
Why?
|
| Histones | 7 | 2021 | 2600 | 0.290 |
Why?
|
| Carcinoma | 4 | 2017 | 2330 | 0.280 |
Why?
|
| DNA Repair | 5 | 2021 | 2050 | 0.280 |
Why?
|
| Risk Factors | 40 | 2024 | 74936 | 0.280 |
Why?
|
| Image Enhancement | 2 | 2009 | 2880 | 0.280 |
Why?
|
| Lung Neoplasms | 10 | 2024 | 13499 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 6 | 2024 | 5798 | 0.270 |
Why?
|
| Polymorphism, Genetic | 6 | 2012 | 4248 | 0.270 |
Why?
|
| Gadolinium DTPA | 2 | 2009 | 823 | 0.270 |
Why?
|
| Early Detection of Cancer | 2 | 2020 | 3237 | 0.270 |
Why?
|
| Nanomedicine | 1 | 2009 | 292 | 0.260 |
Why?
|
| Estrogen Receptor alpha | 1 | 2010 | 581 | 0.260 |
Why?
|
| Middle Aged | 75 | 2024 | 223422 | 0.260 |
Why?
|
| Technology, Radiologic | 1 | 2006 | 160 | 0.260 |
Why?
|
| Selection, Genetic | 1 | 2010 | 877 | 0.250 |
Why?
|
| Cohort Studies | 30 | 2021 | 41749 | 0.250 |
Why?
|
| Interleukin-7 | 2 | 2022 | 146 | 0.250 |
Why?
|
| Adenocarcinoma | 3 | 2021 | 6371 | 0.250 |
Why?
|
| Gene Expression | 4 | 2014 | 7597 | 0.240 |
Why?
|
| Behavioral Medicine | 1 | 2005 | 49 | 0.240 |
Why?
|
| Receptors, Estrogen | 3 | 2022 | 2253 | 0.240 |
Why?
|
| NFI Transcription Factors | 1 | 2024 | 49 | 0.240 |
Why?
|
| Receptors, Progesterone | 1 | 2009 | 1160 | 0.240 |
Why?
|
| Neoplasm Proteins | 4 | 2015 | 3601 | 0.230 |
Why?
|
| RNA, Messenger | 6 | 2016 | 12797 | 0.230 |
Why?
|
| Nitriles | 5 | 2024 | 980 | 0.230 |
Why?
|
| Drug Carriers | 1 | 2009 | 708 | 0.230 |
Why?
|
| Neoplasm Staging | 12 | 2017 | 11221 | 0.230 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2004 | 131 | 0.230 |
Why?
|
| Spheniscidae | 1 | 2023 | 9 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2024 | 185 | 0.230 |
Why?
|
| Female | 100 | 2024 | 397113 | 0.220 |
Why?
|
| Hawaii | 4 | 2007 | 101 | 0.220 |
Why?
|
| Cyclic AMP Response Element-Binding Protein A | 2 | 2022 | 21 | 0.220 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 984 | 0.220 |
Why?
|
| Transcription, Genetic | 5 | 2024 | 7612 | 0.220 |
Why?
|
| Anticarcinogenic Agents | 2 | 2017 | 251 | 0.220 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2011 | 1536 | 0.220 |
Why?
|
| Guidelines as Topic | 5 | 2009 | 1395 | 0.210 |
Why?
|
| Allelic Imbalance | 2 | 2021 | 77 | 0.210 |
Why?
|
| Professional Competence | 1 | 2006 | 430 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2016 | 350 | 0.210 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2022 | 123 | 0.200 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2022 | 1099 | 0.200 |
Why?
|
| Alzheimer Disease | 8 | 1998 | 8761 | 0.200 |
Why?
|
| Genomics | 10 | 2024 | 5925 | 0.200 |
Why?
|
| Colonic Neoplasms | 2 | 2014 | 2540 | 0.200 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2021 | 5 | 0.200 |
Why?
|
| Task Performance and Analysis | 1 | 2006 | 771 | 0.200 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2015 | 1120 | 0.190 |
Why?
|
| Genome, Human | 9 | 2020 | 4443 | 0.190 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2000 | 119 | 0.190 |
Why?
|
| Benzamides | 4 | 2024 | 1377 | 0.190 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 1998 | 1140 | 0.190 |
Why?
|
| Genes, BRCA1 | 1 | 2005 | 755 | 0.190 |
Why?
|
| Disease Progression | 12 | 2021 | 13665 | 0.180 |
Why?
|
| Protein Binding | 5 | 2024 | 9343 | 0.180 |
Why?
|
| Prostate-Specific Antigen | 4 | 2023 | 2463 | 0.180 |
Why?
|
| Nucleotides | 1 | 2023 | 455 | 0.180 |
Why?
|
| Exons | 3 | 2021 | 2393 | 0.180 |
Why?
|
| Odds Ratio | 10 | 2019 | 9666 | 0.180 |
Why?
|
| Colorectal Neoplasms | 4 | 2017 | 6973 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2024 | 582 | 0.170 |
Why?
|
| Genetic Techniques | 2 | 2021 | 427 | 0.170 |
Why?
|
| Lipogenesis | 1 | 2022 | 217 | 0.170 |
Why?
|
| Mutation, Missense | 5 | 2009 | 2592 | 0.170 |
Why?
|
| Neuropsychological Tests | 5 | 2011 | 7140 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2015 | 563 | 0.170 |
Why?
|
| Carcinoma, Lobular | 3 | 2022 | 480 | 0.170 |
Why?
|
| SOXF Transcription Factors | 1 | 2019 | 31 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 3618 | 0.170 |
Why?
|
| Observer Variation | 1 | 2006 | 2618 | 0.170 |
Why?
|
| RNA Interference | 2 | 2021 | 2830 | 0.170 |
Why?
|
| Hematologic Diseases | 3 | 1999 | 498 | 0.170 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 190 | 0.170 |
Why?
|
| Cognition Disorders | 3 | 2011 | 3977 | 0.170 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2019 | 31 | 0.170 |
Why?
|
| Aged, 80 and over | 24 | 2021 | 59598 | 0.170 |
Why?
|
| Chromosomes, Human | 1 | 2021 | 437 | 0.170 |
Why?
|
| Prognosis | 15 | 2024 | 29979 | 0.160 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2019 | 31 | 0.160 |
Why?
|
| Dementia | 5 | 2010 | 2740 | 0.160 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2001 | 277 | 0.160 |
Why?
|
| Phenylenediamines | 1 | 2019 | 89 | 0.160 |
Why?
|
| Transcription Factor AP-1 | 1 | 2020 | 322 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2022 | 5335 | 0.160 |
Why?
|
| Models, Genetic | 6 | 2019 | 3447 | 0.160 |
Why?
|
| Rhabdoid Tumor | 1 | 2021 | 211 | 0.160 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2017 | 858 | 0.160 |
Why?
|
| Acatalasia | 1 | 1998 | 1 | 0.150 |
Why?
|
| Selegiline | 1 | 1998 | 31 | 0.150 |
Why?
|
| Inheritance Patterns | 2 | 2020 | 344 | 0.150 |
Why?
|
| Neoplasm Metastasis | 3 | 2018 | 4904 | 0.150 |
Why?
|
| Prostatectomy | 5 | 2021 | 1786 | 0.150 |
Why?
|
| Personality | 1 | 2001 | 559 | 0.150 |
Why?
|
| Cell Proliferation | 5 | 2024 | 10470 | 0.150 |
Why?
|
| Benzofurans | 1 | 1998 | 138 | 0.150 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1998 | 153 | 0.150 |
Why?
|
| Disability Evaluation | 1 | 2005 | 1835 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1998 | 287 | 0.140 |
Why?
|
| Genetic Linkage | 3 | 2013 | 2342 | 0.140 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 717 | 0.140 |
Why?
|
| Adult | 44 | 2024 | 223583 | 0.140 |
Why?
|
| Aspirin | 3 | 2017 | 3135 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 756 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 9 | 2011 | 6071 | 0.140 |
Why?
|
| Phenotype | 9 | 2023 | 16723 | 0.140 |
Why?
|
| Lipid Peroxidation | 1 | 1998 | 276 | 0.140 |
Why?
|
| Neurology | 1 | 2005 | 786 | 0.140 |
Why?
|
| Oncogenes | 1 | 2023 | 1232 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 832 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2021 | 3669 | 0.140 |
Why?
|
| Glutathione Peroxidase | 1 | 1998 | 259 | 0.140 |
Why?
|
| Mammography | 6 | 2007 | 2433 | 0.130 |
Why?
|
| Penetrance | 3 | 2021 | 385 | 0.130 |
Why?
|
| Pyrrolidines | 1 | 1998 | 340 | 0.130 |
Why?
|
| Psychomotor Performance | 2 | 1998 | 1892 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2015 | 6517 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 4414 | 0.130 |
Why?
|
| Radiography, Interventional | 1 | 2004 | 1130 | 0.130 |
Why?
|
| Genetic Testing | 3 | 2020 | 3589 | 0.130 |
Why?
|
| Mass Screening | 7 | 2008 | 5458 | 0.130 |
Why?
|
| Nuchal Cord | 1 | 2015 | 5 | 0.130 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 2 | 2006 | 58 | 0.130 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1998 | 471 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2000 | 490 | 0.130 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2011 | 553 | 0.130 |
Why?
|
| National Cancer Institute (U.S.) | 3 | 2015 | 300 | 0.130 |
Why?
|
| Predictive Value of Tests | 9 | 2024 | 15442 | 0.130 |
Why?
|
| Cognition | 4 | 2022 | 7072 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2006 | 3389 | 0.120 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 309 | 0.120 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 1625 | 0.120 |
Why?
|
| Prospective Studies | 17 | 2024 | 54924 | 0.120 |
Why?
|
| Radiography, Thoracic | 4 | 2006 | 1321 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2010 | 3463 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 1998 | 596 | 0.120 |
Why?
|
| Anemia, Macrocytic | 2 | 2013 | 53 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 4 | 2021 | 4785 | 0.120 |
Why?
|
| Membrane Proteins | 4 | 2016 | 7876 | 0.120 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2018 | 658 | 0.120 |
Why?
|
| Behavior | 1 | 1998 | 541 | 0.120 |
Why?
|
| Binding Sites | 4 | 2020 | 6022 | 0.120 |
Why?
|
| DNA Damage | 3 | 2021 | 2470 | 0.120 |
Why?
|
| Iodine Radioisotopes | 1 | 1998 | 1034 | 0.120 |
Why?
|
| Telomere | 2 | 2017 | 943 | 0.120 |
Why?
|
| Visual Perception | 2 | 2006 | 1402 | 0.120 |
Why?
|
| Gene Frequency | 5 | 2009 | 3623 | 0.120 |
Why?
|
| Immunoblotting | 2 | 2015 | 1647 | 0.120 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2021 | 794 | 0.110 |
Why?
|
| Computational Biology | 4 | 2019 | 3568 | 0.110 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 427 | 0.110 |
Why?
|
| Organotechnetium Compounds | 1 | 1994 | 132 | 0.110 |
Why?
|
| Neutropenia | 5 | 2001 | 892 | 0.110 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2015 | 263 | 0.110 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 1753 | 0.110 |
Why?
|
| Taxoids | 1 | 2017 | 665 | 0.110 |
Why?
|
| Blood Proteins | 3 | 2016 | 1191 | 0.110 |
Why?
|
| Endometriosis | 1 | 2022 | 873 | 0.110 |
Why?
|
| Disease | 2 | 2009 | 675 | 0.110 |
Why?
|
| Genes | 2 | 2013 | 1824 | 0.110 |
Why?
|
| Publishing | 3 | 2009 | 837 | 0.110 |
Why?
|
| Sensitivity and Specificity | 9 | 2011 | 14718 | 0.110 |
Why?
|
| Receptors, Transferrin | 2 | 2013 | 300 | 0.110 |
Why?
|
| Sorting Nexins | 1 | 2013 | 25 | 0.110 |
Why?
|
| Organ Specificity | 3 | 2016 | 1968 | 0.110 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2013 | 152 | 0.110 |
Why?
|
| DNA Primers | 5 | 2009 | 2827 | 0.100 |
Why?
|
| Isoleucine | 4 | 2007 | 111 | 0.100 |
Why?
|
| Loss of Heterozygosity | 2 | 2006 | 663 | 0.100 |
Why?
|
| Oximes | 1 | 1994 | 303 | 0.100 |
Why?
|
| Survival Rate | 6 | 2020 | 12828 | 0.100 |
Why?
|
| Cell Line | 4 | 2020 | 15597 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 1998 | 1225 | 0.100 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2011 | 16 | 0.100 |
Why?
|
| Research Design | 5 | 2017 | 6211 | 0.100 |
Why?
|
| Threonine | 4 | 2007 | 273 | 0.100 |
Why?
|
| Animals | 31 | 2024 | 169222 | 0.100 |
Why?
|
| DNA-Binding Proteins | 5 | 2020 | 9614 | 0.100 |
Why?
|
| Genes, Neoplasm | 2 | 2021 | 369 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2015 | 2731 | 0.100 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 1991 | 19 | 0.100 |
Why?
|
| Reticulocytes | 6 | 1983 | 287 | 0.090 |
Why?
|
| Regional Blood Flow | 2 | 1996 | 1500 | 0.090 |
Why?
|
| Risk Assessment | 8 | 2017 | 24314 | 0.090 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2011 | 28 | 0.090 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 6843 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2019 | 3609 | 0.090 |
Why?
|
| Catechols | 1 | 2011 | 63 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2006 | 310 | 0.090 |
Why?
|
| Hemoglobins | 7 | 2005 | 1531 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4289 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2009 | 386 | 0.090 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 133 | 0.090 |
Why?
|
| Apolipoprotein E3 | 1 | 2011 | 105 | 0.090 |
Why?
|
| Aging | 4 | 2005 | 8744 | 0.090 |
Why?
|
| Organic Anion Transporters | 1 | 2011 | 101 | 0.090 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2011 | 158 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2022 | 9412 | 0.090 |
Why?
|
| Mental Status Schedule | 1 | 2011 | 315 | 0.090 |
Why?
|
| Reflex, Abnormal | 1 | 2010 | 83 | 0.090 |
Why?
|
| United States | 16 | 2015 | 73027 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2011 | 36742 | 0.090 |
Why?
|
| Antioxidants | 1 | 1998 | 1674 | 0.080 |
Why?
|
| Response Elements | 1 | 2011 | 308 | 0.080 |
Why?
|
| Dominance, Cerebral | 1 | 1991 | 623 | 0.080 |
Why?
|
| Mitochondrial Diseases | 1 | 2013 | 344 | 0.080 |
Why?
|
| Mental Recall | 2 | 1998 | 1226 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2021 | 10098 | 0.080 |
Why?
|
| Lymphocytes | 4 | 1994 | 2614 | 0.080 |
Why?
|
| Base Sequence | 10 | 2019 | 12418 | 0.080 |
Why?
|
| Emotions | 1 | 2001 | 2766 | 0.080 |
Why?
|
| Sequence Analysis | 2 | 2022 | 240 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2013 | 736 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2006 | 2923 | 0.080 |
Why?
|
| Trinucleotide Repeats | 1 | 2010 | 257 | 0.080 |
Why?
|
| Gene Dosage | 2 | 2010 | 1211 | 0.080 |
Why?
|
| Tamoxifen | 2 | 2022 | 966 | 0.080 |
Why?
|
| Orchiectomy | 1 | 2011 | 466 | 0.080 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 138 | 0.080 |
Why?
|
| Anemia | 4 | 2013 | 1514 | 0.080 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2021 | 2195 | 0.080 |
Why?
|
| Genes, Dominant | 1 | 1991 | 855 | 0.080 |
Why?
|
| beta Catenin | 1 | 2013 | 1047 | 0.080 |
Why?
|
| Epithelium | 1 | 2013 | 1607 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 1998 | 2736 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4576 | 0.080 |
Why?
|
| Cell Survival | 1 | 2018 | 5772 | 0.080 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 605 | 0.080 |
Why?
|
| Mice | 14 | 2024 | 82024 | 0.070 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2010 | 243 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 515 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 3 | 2001 | 631 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 2 | 1996 | 2726 | 0.070 |
Why?
|
| Algorithms | 5 | 2020 | 14163 | 0.070 |
Why?
|
| Molecular Epidemiology | 1 | 2009 | 473 | 0.070 |
Why?
|
| Parkinsonian Disorders | 1 | 2010 | 285 | 0.070 |
Why?
|
| GTPase-Activating Proteins | 1 | 2010 | 468 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1642 | 0.070 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2008 | 186 | 0.070 |
Why?
|
| Logistic Models | 4 | 2013 | 13289 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2009 | 320 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2019 | 3046 | 0.070 |
Why?
|
| Histidine | 1 | 2007 | 301 | 0.070 |
Why?
|
| Alternative Splicing | 2 | 2024 | 1104 | 0.070 |
Why?
|
| Sequence Tagged Sites | 1 | 2006 | 96 | 0.070 |
Why?
|
| Mass Chest X-Ray | 1 | 2006 | 18 | 0.070 |
Why?
|
| RNA, Neoplasm | 2 | 2009 | 748 | 0.070 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2016 | 1077 | 0.070 |
Why?
|
| Ibuprofen | 1 | 1988 | 229 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2020 | 806 | 0.070 |
Why?
|
| Leucine | 2 | 2007 | 547 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 2 | 2005 | 273 | 0.070 |
Why?
|
| Epidemiology | 1 | 2009 | 278 | 0.070 |
Why?
|
| Reproducibility of Results | 7 | 2015 | 20218 | 0.070 |
Why?
|
| Adenoma | 1 | 2017 | 2159 | 0.070 |
Why?
|
| Adipocytes | 1 | 2013 | 1197 | 0.070 |
Why?
|
| Azepines | 2 | 2018 | 329 | 0.060 |
Why?
|
| Jehovah's Witnesses | 1 | 2005 | 13 | 0.060 |
Why?
|
| Proline | 1 | 2007 | 455 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2011 | 4114 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2014 | 3804 | 0.060 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2010 | 606 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.060 |
Why?
|
| Los Angeles | 1 | 2006 | 245 | 0.060 |
Why?
|
| Iron | 4 | 2013 | 1813 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2022 | 1144 | 0.060 |
Why?
|
| Blood Substitutes | 1 | 2005 | 57 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 2011 | 1082 | 0.060 |
Why?
|
| Glucose | 1 | 1997 | 4351 | 0.060 |
Why?
|
| DNA | 5 | 2020 | 7213 | 0.060 |
Why?
|
| Ovary | 2 | 2020 | 965 | 0.060 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2011 | 1149 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2005 | 82 | 0.060 |
Why?
|
| Signal Transduction | 9 | 2022 | 23642 | 0.060 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2011 | 617 | 0.060 |
Why?
|
| Reaction Time | 1 | 1991 | 2098 | 0.060 |
Why?
|
| Nucleosomes | 2 | 2023 | 492 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 11930 | 0.060 |
Why?
|
| Molecular Sequence Annotation | 2 | 2018 | 527 | 0.060 |
Why?
|
| Nephrectomy | 2 | 2024 | 930 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2007 | 1989 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2019 | 3703 | 0.060 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2024 | 101 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 1326 | 0.060 |
Why?
|
| Joint Diseases | 1 | 1988 | 461 | 0.060 |
Why?
|
| Melanoma | 1 | 2022 | 5706 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2011 | 1802 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3096 | 0.060 |
Why?
|
| Introns | 1 | 2006 | 966 | 0.060 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 2 | 1993 | 38 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2024 | 1901 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 2906 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 3 | 2017 | 1363 | 0.050 |
Why?
|
| Cell Cycle Proteins | 3 | 2024 | 3443 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 1837 | 0.050 |
Why?
|
| Tyrosine | 1 | 2007 | 1427 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2021 | 456 | 0.050 |
Why?
|
| Thorax | 1 | 2006 | 557 | 0.050 |
Why?
|
| Neurons | 2 | 2022 | 9518 | 0.050 |
Why?
|
| Obesity | 3 | 2019 | 13091 | 0.050 |
Why?
|
| Chromosome Inversion | 2 | 1993 | 119 | 0.050 |
Why?
|
| Mammaplasty | 1 | 2013 | 1268 | 0.050 |
Why?
|
| Blood Transfusion | 3 | 2005 | 1308 | 0.050 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2003 | 99 | 0.050 |
Why?
|
| Age of Onset | 2 | 2007 | 3347 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2005 | 506 | 0.050 |
Why?
|
| Triazoles | 2 | 2018 | 904 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2005 | 693 | 0.050 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2024 | 304 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 784 | 0.050 |
Why?
|
| California | 1 | 2006 | 1438 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2019 | 1040 | 0.050 |
Why?
|
| Blood Cell Count | 3 | 1983 | 406 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2010 | 2953 | 0.050 |
Why?
|
| Radiographic Image Enhancement | 2 | 2004 | 877 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3798 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 97 | 0.050 |
Why?
|
| Nuclear Proteins | 4 | 2020 | 5799 | 0.050 |
Why?
|
| Heterozygote | 3 | 2019 | 2798 | 0.050 |
Why?
|
| Neurologic Examination | 1 | 2005 | 914 | 0.050 |
Why?
|
| Young Adult | 7 | 2021 | 60048 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 1993 | 341 | 0.050 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 12075 | 0.050 |
Why?
|
| Models, Biological | 7 | 2011 | 9493 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2000 | 2710 | 0.050 |
Why?
|
| Research | 2 | 2009 | 1979 | 0.050 |
Why?
|
| Genealogy and Heraldry | 1 | 2021 | 29 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2013 | 6228 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2022 | 129 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2005 | 716 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2005 | 2357 | 0.050 |
Why?
|
| Thrombospondins | 1 | 2001 | 196 | 0.050 |
Why?
|
| Body Mass Index | 4 | 2019 | 13053 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2022 | 287 | 0.050 |
Why?
|
| Testosterone | 3 | 2022 | 2491 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2019 | 8314 | 0.040 |
Why?
|
| Cerebellum | 2 | 1998 | 1522 | 0.040 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2001 | 53 | 0.040 |
Why?
|
| Attention | 1 | 1991 | 2424 | 0.040 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 13658 | 0.040 |
Why?
|
| Apolipoproteins E | 2 | 1998 | 1461 | 0.040 |
Why?
|
| Methylmalonic Acid | 1 | 2000 | 51 | 0.040 |
Why?
|
| Genes, cdc | 1 | 2020 | 113 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2011 | 20757 | 0.040 |
Why?
|
| Proteins | 3 | 2023 | 6009 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2017 | 12464 | 0.040 |
Why?
|
| Brain | 4 | 2005 | 27366 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2022 | 2982 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2024 | 1715 | 0.040 |
Why?
|
| Apoptosis | 4 | 1998 | 9521 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2024 | 2857 | 0.040 |
Why?
|
| T-Lymphocytes | 5 | 2000 | 10264 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 292 | 0.040 |
Why?
|
| Computer Simulation | 5 | 2020 | 6283 | 0.040 |
Why?
|
| Postmenopause | 2 | 2008 | 2518 | 0.040 |
Why?
|
| Kidney | 2 | 2021 | 7065 | 0.040 |
Why?
|
| Patient Selection | 2 | 2004 | 4258 | 0.040 |
Why?
|
| Ribosomes | 4 | 1976 | 497 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 1972 | 0.040 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2024 | 454 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 709 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2019 | 179 | 0.040 |
Why?
|
| Pedigree | 3 | 2017 | 4539 | 0.040 |
Why?
|
| Thalassemia | 2 | 1983 | 267 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2022 | 81746 | 0.040 |
Why?
|
| Heme | 3 | 1976 | 316 | 0.040 |
Why?
|
| Benzene | 2 | 1976 | 106 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2009 | 6119 | 0.040 |
Why?
|
| Adolescent | 13 | 2021 | 89155 | 0.040 |
Why?
|
| ROC Curve | 2 | 2024 | 3628 | 0.040 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1998 | 45 | 0.040 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 1999 | 84 | 0.040 |
Why?
|
| Prevalence | 6 | 2010 | 15867 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11873 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 1998 | 102 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 240 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4648 | 0.040 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2019 | 149 | 0.040 |
Why?
|
| Affective Symptoms | 1 | 2001 | 418 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 4791 | 0.040 |
Why?
|
| Streptococcus mutans | 1 | 1978 | 99 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2009 | 1465 | 0.040 |
Why?
|
| Age Factors | 4 | 2017 | 18407 | 0.040 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2000 | 265 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 1280 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 706 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2004 | 1119 | 0.040 |
Why?
|
| Massachusetts | 1 | 2010 | 8888 | 0.040 |
Why?
|
| Psychosurgery | 1 | 1998 | 86 | 0.040 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2001 | 399 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 1995 | 4168 | 0.040 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2000 | 235 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 1998 | 610 | 0.040 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 1997 | 21 | 0.040 |
Why?
|
| Heredity | 1 | 2017 | 149 | 0.040 |
Why?
|
| Hexokinase | 1 | 1997 | 124 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 507 | 0.030 |
Why?
|
| Homocysteine | 1 | 2000 | 637 | 0.030 |
Why?
|
| Thrombocytosis | 1 | 1977 | 88 | 0.030 |
Why?
|
| Interferons | 1 | 2021 | 720 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 2 | 1976 | 1065 | 0.030 |
Why?
|
| Health Behavior | 1 | 2008 | 2650 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1605 | 0.030 |
Why?
|
| Spinal Cord Diseases | 1 | 2000 | 291 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 1997 | 333 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2004 | 1232 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2020 | 564 | 0.030 |
Why?
|
| Plasma | 1 | 2020 | 584 | 0.030 |
Why?
|
| Peptide Biosynthesis | 3 | 1971 | 52 | 0.030 |
Why?
|
| Polycythemia | 1 | 1997 | 124 | 0.030 |
Why?
|
| Radiography | 2 | 2005 | 6983 | 0.030 |
Why?
|
| Immunity | 1 | 2022 | 1003 | 0.030 |
Why?
|
| Molecular Sequence Data | 8 | 1996 | 17617 | 0.030 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1996 | 67 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2019 | 818 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2001 | 896 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2006 | 1944 | 0.030 |
Why?
|
| Aggression | 1 | 2001 | 750 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2006 | 2594 | 0.030 |
Why?
|
| Monosomy | 1 | 1995 | 52 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1996 | 2568 | 0.030 |
Why?
|
| Contrast Media | 1 | 2009 | 5330 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
| Blood Platelets | 2 | 1977 | 2479 | 0.030 |
Why?
|
| Community Networks | 1 | 1997 | 202 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 2 | 2020 | 2708 | 0.030 |
Why?
|
| Gamma Rays | 2 | 1994 | 319 | 0.030 |
Why?
|
| Zebrafish | 3 | 2013 | 3036 | 0.030 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2017 | 292 | 0.030 |
Why?
|
| Genetic Vectors | 3 | 1994 | 3402 | 0.030 |
Why?
|
| Health Services for the Aged | 1 | 1997 | 264 | 0.030 |
Why?
|
| Family | 3 | 2016 | 3210 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 15944 | 0.030 |
Why?
|
| Spinal Diseases | 1 | 2000 | 561 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2020 | 854 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2016 | 248 | 0.030 |
Why?
|
| Incidence | 4 | 2009 | 21532 | 0.030 |
Why?
|
| Forecasting | 1 | 2004 | 2945 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2020 | 1165 | 0.030 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1994 | 61 | 0.030 |
Why?
|
| Apolipoproteins C | 1 | 1994 | 59 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1997 | 1126 | 0.030 |
Why?
|
| Orbit | 1 | 1998 | 459 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 2230 | 0.030 |
Why?
|
| Cell Count | 1 | 1998 | 1831 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1998 | 958 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2001 | 1209 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2015 | 266 | 0.030 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 1994 | 74 | 0.030 |
Why?
|
| Hominidae | 1 | 1994 | 68 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2015 | 472 | 0.030 |
Why?
|
| Epinephrine | 1 | 1977 | 793 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2017 | 753 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 4055 | 0.030 |
Why?
|
| Multiple Sclerosis | 2 | 2001 | 3250 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 1904 | 0.030 |
Why?
|
| Iron Overload | 1 | 1996 | 245 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2627 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 2048 | 0.030 |
Why?
|
| Dental Caries | 1 | 1978 | 429 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2022 | 2881 | 0.030 |
Why?
|
| Energy Intake | 1 | 2001 | 2145 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2022 | 4146 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2001 | 2001 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 22381 | 0.030 |
Why?
|
| Genes, ras | 1 | 1995 | 657 | 0.030 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 39345 | 0.030 |
Why?
|
| DNA Replication | 2 | 2007 | 1427 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1752 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2013 | 724 | 0.030 |
Why?
|
| Cell Differentiation | 3 | 2024 | 11665 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2013 | 221 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2019 | 19017 | 0.030 |
Why?
|
| Neutrophils | 3 | 2001 | 3786 | 0.030 |
Why?
|
| Microcirculation | 1 | 1997 | 1281 | 0.030 |
Why?
|
| Growth Substances | 1 | 1995 | 759 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2013 | 4857 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2020 | 2766 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1758 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1994 | 876 | 0.020 |
Why?
|
| Myosins | 1 | 1993 | 408 | 0.020 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 1996 | 372 | 0.020 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2011 | 25 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 781 | 0.020 |
Why?
|
| Presenilin-1 | 1 | 1995 | 666 | 0.020 |
Why?
|
| Plasmids | 2 | 1994 | 2269 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2001 | 2429 | 0.020 |
Why?
|
| Point Mutation | 1 | 1997 | 1594 | 0.020 |
Why?
|
| Ataxia Telangiectasia | 1 | 1992 | 107 | 0.020 |
Why?
|
| Diagnosis, Differential | 6 | 1998 | 13000 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1443 | 0.020 |
Why?
|
| Child, Preschool | 8 | 2021 | 42665 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 2591 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1526 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 2456 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2800 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2001 | 1437 | 0.020 |
Why?
|
| Life Expectancy | 1 | 1997 | 1248 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 3488 | 0.020 |
Why?
|
| Mitochondria | 1 | 2004 | 3681 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 1141 | 0.020 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2011 | 241 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2011 | 313 | 0.020 |
Why?
|
| Early Diagnosis | 2 | 2006 | 1193 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 252 | 0.020 |
Why?
|
| Sex Factors | 2 | 2019 | 10627 | 0.020 |
Why?
|
| Positron-Emission Tomography | 2 | 2023 | 6668 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1998 | 1726 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2018 | 2358 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2009 | 5107 | 0.020 |
Why?
|
| Morbidity | 1 | 2015 | 1754 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2017 | 65364 | 0.020 |
Why?
|
| Kinetics | 1 | 1997 | 6328 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3948 | 0.020 |
Why?
|
| Cross-Sectional Studies | 4 | 2008 | 26375 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2013 | 691 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2902 | 0.020 |
Why?
|
| Genetic Phenomena | 1 | 2009 | 6 | 0.020 |
Why?
|
| Time Factors | 5 | 2017 | 40214 | 0.020 |
Why?
|
| Nuclear Family | 2 | 2001 | 311 | 0.020 |
Why?
|
| Leukocytes | 1 | 2017 | 2035 | 0.020 |
Why?
|
| Antigens | 1 | 1995 | 1442 | 0.020 |
Why?
|
| Stem Cells | 1 | 2022 | 3537 | 0.020 |
Why?
|
| Hematocrit | 2 | 1997 | 623 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 3231 | 0.020 |
Why?
|
| Rabbits | 6 | 1977 | 4771 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2001 | 3205 | 0.020 |
Why?
|
| Likelihood Functions | 2 | 2003 | 994 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 1998 | 2008 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2473 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2011 | 4525 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2004 | 8082 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 361 | 0.020 |
Why?
|
| Lymphocyte Count | 2 | 2001 | 794 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2543 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1892 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2015 | 2673 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 5446 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2001 | 313 | 0.020 |
Why?
|
| Child | 9 | 2021 | 80906 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1998 | 6029 | 0.020 |
Why?
|
| Hodgkin Disease | 2 | 1990 | 1383 | 0.020 |
Why?
|
| Lipids | 1 | 2019 | 3342 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 979 | 0.020 |
Why?
|
| Erythropoietin | 2 | 2005 | 718 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2011 | 794 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1992 | 1384 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2015 | 1608 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2011 | 674 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 800 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 2006 | 4362 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 1998 | 3140 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 2085 | 0.020 |
Why?
|
| Cough | 1 | 1990 | 598 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 1995 | 1594 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1505 | 0.020 |
Why?
|
| Biopsy | 3 | 2005 | 6786 | 0.020 |
Why?
|
| Microscopy, Scanning Probe | 1 | 2006 | 6 | 0.020 |
Why?
|
| Hemosiderin | 1 | 2005 | 41 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2006 | 202 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18344 | 0.020 |
Why?
|
| Cytokines | 2 | 2017 | 7450 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 1988 | 684 | 0.020 |
Why?
|
| Hippocampus | 1 | 1998 | 3786 | 0.020 |
Why?
|
| Nigeria | 1 | 2008 | 781 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1995 | 1399 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2000 | 3532 | 0.020 |
Why?
|
| Cyclin B | 1 | 2005 | 104 | 0.020 |
Why?
|
| Psychotic Disorders | 1 | 2001 | 3276 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5024 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2001 | 6515 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2000 | 9016 | 0.020 |
Why?
|
| Diuretics | 1 | 1988 | 614 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1994 | 2322 | 0.010 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2004 | 67 | 0.010 |
Why?
|
| Insulin | 1 | 2019 | 6606 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2019 | 6429 | 0.010 |
Why?
|
| K562 Cells | 1 | 2006 | 644 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9368 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 943 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2271 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2006 | 287 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 2005 | 5314 | 0.010 |
Why?
|
| Homozygote | 2 | 2001 | 1778 | 0.010 |
Why?
|
| Random Allocation | 1 | 1988 | 2396 | 0.010 |
Why?
|
| Chlorambucil | 1 | 1983 | 42 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1997 | 3626 | 0.010 |
Why?
|
| Pilot Projects | 3 | 2004 | 8740 | 0.010 |
Why?
|
| Syndrome | 2 | 2000 | 3271 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14486 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2019 | 8540 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2004 | 571 | 0.010 |
Why?
|
| Diet | 1 | 2001 | 8087 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1993 | 849 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1983 | 311 | 0.010 |
Why?
|
| Infant | 6 | 2001 | 36534 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 2004 | 297 | 0.010 |
Why?
|
| Mammary Glands, Human | 1 | 2004 | 202 | 0.010 |
Why?
|
| Chemoprevention | 1 | 2004 | 327 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2009 | 1610 | 0.010 |
Why?
|
| Erythrocyte Indices | 1 | 1983 | 143 | 0.010 |
Why?
|
| Clone Cells | 2 | 1996 | 1669 | 0.010 |
Why?
|
| Globins | 3 | 1974 | 405 | 0.010 |
Why?
|
| Nipples | 1 | 2004 | 227 | 0.010 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 550 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2005 | 910 | 0.010 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2001 | 62 | 0.010 |
Why?
|
| Liposomes | 1 | 2006 | 790 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 6569 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2000 | 5717 | 0.010 |
Why?
|
| Polycythemia Vera | 1 | 1983 | 160 | 0.010 |
Why?
|
| Bacterial Infections | 2 | 2000 | 1397 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1836 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 2227 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 11519 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15660 | 0.010 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2001 | 276 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3428 | 0.010 |
Why?
|
| Platelet Count | 1 | 1983 | 787 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 1177 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1991 | 3113 | 0.010 |
Why?
|
| Splenomegaly | 1 | 2001 | 192 | 0.010 |
Why?
|
| Nanotechnology | 1 | 2006 | 714 | 0.010 |
Why?
|
| Thrombospondin 1 | 1 | 2001 | 257 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 1983 | 529 | 0.010 |
Why?
|
| Congresses as Topic | 1 | 2005 | 812 | 0.010 |
Why?
|
| Ontario | 1 | 2001 | 403 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 3819 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 483 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2000 | 510 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 2001 | 609 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1999 | 84 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 2001 | 642 | 0.010 |
Why?
|
| Trypsinogen | 1 | 1999 | 84 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2006 | 3620 | 0.010 |
Why?
|
| Hemin | 2 | 1976 | 51 | 0.010 |
Why?
|
| Diet, Vegetarian | 1 | 2001 | 181 | 0.010 |
Why?
|
| Data Display | 1 | 2000 | 174 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2001 | 360 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 2 | 1983 | 582 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1971 | 458 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 1880 | 0.010 |
Why?
|
| Schizophrenia | 1 | 1998 | 6983 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 2000 | 0.010 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2004 | 1134 | 0.010 |
Why?
|
| Delusions | 1 | 2001 | 300 | 0.010 |
Why?
|
| Dextranase | 1 | 1978 | 2 | 0.010 |
Why?
|
| Bone Diseases, Developmental | 1 | 1999 | 132 | 0.010 |
Why?
|
| Polymers | 1 | 2005 | 1627 | 0.010 |
Why?
|
| Computer Systems | 1 | 2000 | 469 | 0.010 |
Why?
|
| Adhesiveness | 1 | 1978 | 52 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 1999 | 313 | 0.010 |
Why?
|
| Hallucinations | 1 | 2001 | 373 | 0.010 |
Why?
|
| Pneumococcal Infections | 1 | 1983 | 529 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 12536 | 0.010 |
Why?
|
| Health | 1 | 2001 | 398 | 0.010 |
Why?
|
| Systems Integration | 1 | 2000 | 430 | 0.010 |
Why?
|
| Glucans | 1 | 1978 | 71 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 2005 | 6314 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 2001 | 487 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1995 | 8052 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 2000 | 301 | 0.010 |
Why?
|
| Diet Surveys | 1 | 2001 | 1160 | 0.010 |
Why?
|
| Demography | 1 | 2001 | 1641 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3701 | 0.010 |
Why?
|
| Ultraviolet Rays | 3 | 1971 | 1104 | 0.010 |
Why?
|
| Public Health | 1 | 2009 | 2679 | 0.010 |
Why?
|
| Gasoline | 1 | 1976 | 49 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1977 | 266 | 0.010 |
Why?
|
| Fever | 2 | 2000 | 1613 | 0.010 |
Why?
|
| Triage | 1 | 2003 | 996 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2000 | 680 | 0.010 |
Why?
|
| Petroleum | 1 | 1976 | 82 | 0.010 |
Why?
|
| Splenectomy | 1 | 1977 | 392 | 0.010 |
Why?
|
| Myeloid Cells | 1 | 2001 | 839 | 0.010 |
Why?
|
| Procarbazine | 2 | 1990 | 172 | 0.010 |
Why?
|
| Mechlorethamine | 2 | 1990 | 129 | 0.010 |
Why?
|
| Canada | 1 | 2001 | 2129 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1995 | 325 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2001 | 802 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2005 | 2935 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2000 | 1392 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1996 | 322 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1996 | 411 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1977 | 1377 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2001 | 1390 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1996 | 826 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2000 | 26420 | 0.010 |
Why?
|
| Apolipoprotein C-II | 1 | 1994 | 15 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7851 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1977 | 668 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 12252 | 0.010 |
Why?
|
| Growth Disorders | 1 | 1999 | 635 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 2005 | 7470 | 0.010 |
Why?
|
| TATA Box | 1 | 1994 | 127 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1971 | 186 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1974 | 102 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 2000 | 905 | 0.010 |
Why?
|
| Women's Health | 1 | 2004 | 2082 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1993 | 113 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1561 | 0.010 |
Why?
|
| Cosmids | 1 | 1993 | 105 | 0.010 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 1993 | 42 | 0.010 |
Why?
|
| Core Binding Factors | 1 | 1993 | 29 | 0.010 |
Why?
|
| Spectrophotometry | 2 | 1971 | 292 | 0.010 |
Why?
|
| Superantigens | 1 | 1994 | 124 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1974 | 222 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 2000 | 997 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 2863 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1996 | 877 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10757 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 1993 | 78 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 1993 | 110 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 1999 | 4833 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2000 | 1407 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 2414 | 0.010 |
Why?
|
| Glutathione | 1 | 1976 | 589 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1996 | 13420 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1994 | 1057 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1978 | 2487 | 0.010 |
Why?
|
| Robotics | 1 | 2000 | 813 | 0.010 |
Why?
|
| Vincristine | 2 | 1990 | 1040 | 0.010 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 1993 | 157 | 0.010 |
Why?
|
| Age Distribution | 1 | 1998 | 2871 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 9556 | 0.010 |
Why?
|
| X Chromosome | 1 | 1996 | 819 | 0.010 |
Why?
|
| Jews | 1 | 1994 | 359 | 0.010 |
Why?
|
| Dogs | 1 | 1977 | 3844 | 0.010 |
Why?
|
| Bilirubin | 1 | 1974 | 438 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2000 | 1014 | 0.010 |
Why?
|
| Hemolysis | 1 | 1974 | 417 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 705 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2000 | 1815 | 0.010 |
Why?
|
| Puromycin | 1 | 1971 | 41 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1971 | 298 | 0.010 |
Why?
|
| Celiac Disease | 1 | 1999 | 820 | 0.010 |
Why?
|
| Genetic Code | 1 | 1971 | 139 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 798 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1162 | 0.010 |
Why?
|
| Antimetabolites | 1 | 1971 | 128 | 0.010 |
Why?
|
| Prednisone | 2 | 1990 | 1567 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2000 | 2381 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1974 | 1609 | 0.010 |
Why?
|
| Lead | 1 | 1976 | 882 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2001 | 4541 | 0.010 |
Why?
|
| Endoscopy | 1 | 2000 | 1854 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 9089 | 0.010 |
Why?
|
| Valine | 1 | 1971 | 410 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1976 | 2004 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 1892 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1993 | 931 | 0.010 |
Why?
|
| Spleen | 1 | 1975 | 2295 | 0.010 |
Why?
|
| Weight Loss | 1 | 2001 | 2721 | 0.010 |
Why?
|
| Neurofibromatosis 1 | 1 | 1994 | 561 | 0.000 |
Why?
|
| Graft Survival | 1 | 2000 | 3887 | 0.000 |
Why?
|
| Models, Chemical | 1 | 1971 | 610 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1976 | 2094 | 0.000 |
Why?
|
| Sepsis | 1 | 1983 | 2608 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1971 | 1435 | 0.000 |
Why?
|
| Survivors | 1 | 1999 | 2381 | 0.000 |
Why?
|
| Radiotherapy Dosage | 2 | 1990 | 2916 | 0.000 |
Why?
|
| Methylation | 1 | 1971 | 1078 | 0.000 |
Why?
|
| Protein Multimerization | 1 | 1993 | 965 | 0.000 |
Why?
|
| Peptide Hydrolases | 1 | 1971 | 610 | 0.000 |
Why?
|
| Trypsin | 1 | 1968 | 491 | 0.000 |
Why?
|
| Autoradiography | 1 | 1968 | 727 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 7445 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3740 | 0.000 |
Why?
|
| Molecular Biology | 1 | 1971 | 573 | 0.000 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1993 | 2510 | 0.000 |
Why?
|
| Graft vs Host Disease | 1 | 2000 | 3049 | 0.000 |
Why?
|
| Software | 1 | 2001 | 4478 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1968 | 449 | 0.000 |
Why?
|
| Spinal Cord | 1 | 1994 | 1811 | 0.000 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1990 | 594 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1994 | 2932 | 0.000 |
Why?
|
| Communication | 1 | 2000 | 3904 | 0.000 |
Why?
|
| Health Promotion | 1 | 1997 | 2210 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 5505 | 0.000 |
Why?
|
| Arginine | 1 | 1968 | 932 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1983 | 5196 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1974 | 2418 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1977 | 2496 | 0.000 |
Why?
|
| Lysine | 1 | 1968 | 1000 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11068 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1990 | 723 | 0.000 |
Why?
|
| Recurrence | 2 | 1990 | 8507 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1993 | 2680 | 0.000 |
Why?
|
| Radiation Injuries | 1 | 1990 | 1198 | 0.000 |
Why?
|
| Rats | 1 | 1978 | 23751 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1979 | 384 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1990 | 8535 | 0.000 |
Why?
|
| Poly C | 1 | 1977 | 6 | 0.000 |
Why?
|
| Streptococcus pneumoniae | 1 | 1983 | 764 | 0.000 |
Why?
|
| Seasons | 1 | 1983 | 1524 | 0.000 |
Why?
|
| Polyribosomes | 1 | 1976 | 109 | 0.000 |
Why?
|
| Peritoneal Dialysis | 1 | 1977 | 161 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1990 | 9384 | 0.000 |
Why?
|
| Alcoholism | 1 | 1983 | 1980 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1976 | 1760 | 0.000 |
Why?
|
| Creatinine | 1 | 1977 | 1918 | 0.000 |
Why?
|
| Psychological Tests | 1 | 1953 | 643 | 0.000 |
Why?
|
| Iron Isotopes | 1 | 1969 | 19 | 0.000 |
Why?
|
| Cell Division | 1 | 1977 | 4473 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1969 | 305 | 0.000 |
Why?
|
| Deuterium | 1 | 1969 | 106 | 0.000 |
Why?
|
| Models, Structural | 1 | 1969 | 340 | 0.000 |
Why?
|
| Hemoglobins, Abnormal | 1 | 1969 | 119 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1969 | 339 | 0.000 |
Why?
|
| Metabolism | 1 | 1969 | 193 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1977 | 1791 | 0.000 |
Why?
|
| RNA, Bacterial | 1 | 1969 | 393 | 0.000 |
Why?
|
| Porphyrins | 1 | 1969 | 352 | 0.000 |
Why?
|
| RNA, Transfer | 1 | 1969 | 284 | 0.000 |
Why?
|
| Stress, Physiological | 1 | 1953 | 1409 | 0.000 |
Why?
|
| Hospitalization | 1 | 1983 | 10840 | 0.000 |
Why?
|
| Temperature | 1 | 1969 | 2234 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1977 | 4261 | 0.000 |
Why?
|
| Stress, Psychological | 1 | 1953 | 4530 | 0.000 |
Why?
|
| Pyridines | 1 | 1969 | 2893 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1953 | 6875 | 0.000 |
Why?
|
| Hypertension | 1 | 1953 | 8616 | 0.000 |
Why?
|
| Liver | 1 | 1969 | 7574 | 0.000 |
Why?
|